STAT+: Missouri AG warns Lilly to stop requiring data from hospitals seeking 340B drug discounts

Missouri's Attorney General has warned Eli Lilly to immediately stop requiring hospitals to submit claims data to access 340B drug discounts. The directive signals an escalating pushback from state officials against pharmaceutical manufacturers attempting to restrict discounted drug sales to safety-net healthcare providers. The conflict represents the latest front in a broader, nationwide dispute over manufacturer-imposed conditions on contract pharmacy arrangements.